Second-line chemotherapy for advanced gastric cancer in Korea

By Baek Sun   Kim Si-Young   Jeong Jae-heon   Cho Kyung   Yoon Hwi-Joong  

Gastric Cancer, Vol. 15, Iss. 4, 2012-10 ,pp. : 345-354

Springer Publishing Company

Access to resources Recommend Favorite

Second-line chemotherapy with irinotecan plus cisplatin after the failure of S-1 monotherapy for advanced gastric cancer

By Takahari Daisuke   Shimada Yasuhiro   Takeshita Shigeyuki   Nishitani Hitoshi   Takashima Atsuo   Okita Natsuko   Hirashima Yoshinori   Kato Ken   Hamaguchi Tetsuya   Yamada Yasuhide   Shirao Kuniaki  

Gastric Cancer, Vol. 13, Iss. 3, 2010-08 ,pp. : 186-190

Springer Publishing Company

Access to resources Recommend Favorite

Taxol as Second-Line Treatment in Patients with Advanced Ovarian Cancer after Platinum-Based First-Line Chemotherapy

By Mayerhofer K.   Kucera E.   Zeisler H.   Speiser P.   Reinthaller A.   Sevelda P.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 109-113

Elsevier

Access to resources Recommend Favorite

Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer

By Barone Carlo   Basso Michele   Schinzari Giovanni   Pozzo Carmelo   Trigila Nunziatina   D'Argento Ettore   Quirino Michela   Astone Antonio   Cassano Alessandra  

Gastric Cancer, Vol. 10, Iss. 2, 2007-06 ,pp. : 104-111

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of bevacizumab combined with irinotecan and S-1 as second-line chemotherapy in patients with advanced colorectal cancer

By Kusaba Hitoshi   Esaki Taito   Kishimoto Junji   Uchino Keita   Arita Shuji   Kumagai Hozumi   Mitsugi Kenji   Akashi Koichi   Baba Eishi  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 29-34

Springer Publishing Company

Access to resources Recommend Favorite